Deep learning technology provides "urgency scores" and
AI-generated diagnoses that even non-experts can understand – so
patients can receive rapid, critical treatment
TEL
AVIV, Israel, May 2, 2024
/PRNewswire/ -- AISAP, whose AI-powered Point Of Care
Assisted Diagnosis (POCAD)™ solution is transforming the medical
ultrasound industry, announced its seed funding round today. The
company secured $13 million, led by
Harel Insurance Investments & Financial Services Ltd. and Shoni
Top Ventures, L.P.
Ultrasound scans are crucial for discovering and diagnosing many
medical conditions. However, it can often take weeks or months to
receive a diagnosis, primarily due to a chronic lack of qualified
medical professionals, as well as the logistical difficulties of
transporting patients to the scan. As a result, many patients get
left behind. While portable POCUS devices do exist – removing the
need to transport patients to and from scans – these devices don't
solve the fundamental problem, as they, too, can only be operated
by experts.
AISAP's POCAD™ solution solves this challenge by providing
AI-powered diagnoses that are both highly accurate and easy for any
physician to understand – not just ultrasound experts. This
includes a unique "urgency score" that enables medical providers to
prioritize cases based on the severity of the condition; a score
that measures the quality of the scan for operators, to ensure
accuracy even if they are less familiar with traditional ultrasound
devices; and Deep Learning AI capabilities that enable accurate
readings even with lower-quality images from handheld machines.
Unlike most other POCUS devices, AISAP's POCAD™ solution can even
provide detailed, accurate diagnoses of specific valves within the
cardiovascular systems. And while the average ultrasound takes
weeks on average to provide a full analysis and diagnosis, AISAP's
solution does so in as little as 5 minutes.
AISAP's algorithms have been trained on more than 300,000
studies comprising over 24 million video clips, and the technology
has been validated by a range of medical experts from The Mayo
Clinic, Inova Health Foundation, Jefferson Health, Poriya Institute
and more.
In a recent study – still currently under review at Israel's Sheba Medical Center – 660 patients
who had not received a full ultrasound underwent AISAP scans at the
Emergency Department or Internal Medicine units. In 29% of those
cases, the AISAP solution discovered at least one
previously-unknown, moderate medical condition.
AISAP was founded by a unique group of experts from the medical,
technology and intelligence worlds, united in their vision for
universally accessible medical care. Its co-founders are Adiel
Am-Shalom – who managed R&D and Cyber teams in the Israel
Defense Force's elite 8200 intelligence unit and the founder of
IDL; Ehud Raanani – Director of the Leviev Cardiovascular and
Thoracic Center at Israel's Sheba
Medical Center; Robert Klempfner –
Director of the Israeli Center for Cardiovascular Research; and
Ehud Schwammenthal – a world-renowned expert in echocardiography
and the founder of both Ventor Technologies and Magenta Medical.
While AISAP's POCAD™ solution is currently focused on the area of
cardiac medicine, the company is developing additional products in
other anatomical areas as well.
"Obtaining an accurate ultrasound diagnosis in time can
literally be the difference between life and death, so the fact
that so many patients are forced to wait up to a month for one is
nothing short of a global health crisis," says AISAP CEO
Roni Attali. "This problem is
particularly acute in rural areas or those with fewer resources,
and therefore disproportionately impacts disadvantaged
populations."
"It's hard to overstate the potential impact of AISAP's
solution," states Tamir Pardo, a
former head of Israel's Mossad
covert intelligence agency who today heads AISAP's Strategic Board.
"The ability to provide critical diagnoses anywhere, anytime,
without the need for a dedicated expert, is a paradigm shift that
could save countless lives. That was reason enough for me to make
AISAP's mission my own, and this investment is a crucial milestone
in achieving this lofty goal."
Media Contact
Lazer Cohen
Concrete Media
347-753-8256
lazer@concrete.media
View original
content:https://www.prnewswire.com/news-releases/aisap-raises-13-million-in-seed-funding-for-first-ai-powered-point-of-care-ultrasound-diagnostic-solution-302134639.html
SOURCE AISAP